Correlation Between Agios Pharm and Arvinas

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agios Pharm and Arvinas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agios Pharm and Arvinas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agios Pharm and Arvinas, you can compare the effects of market volatilities on Agios Pharm and Arvinas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agios Pharm with a short position of Arvinas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agios Pharm and Arvinas.

Diversification Opportunities for Agios Pharm and Arvinas

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Agios and Arvinas is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Agios Pharm and Arvinas in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arvinas and Agios Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agios Pharm are associated (or correlated) with Arvinas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arvinas has no effect on the direction of Agios Pharm i.e., Agios Pharm and Arvinas go up and down completely randomly.

Pair Corralation between Agios Pharm and Arvinas

Given the investment horizon of 90 days Agios Pharm is expected to generate 0.85 times more return on investment than Arvinas. However, Agios Pharm is 1.18 times less risky than Arvinas. It trades about 0.17 of its potential returns per unit of risk. Arvinas is currently generating about 0.04 per unit of risk. If you would invest  4,473  in Agios Pharm on September 2, 2024 and sell it today you would earn a total of  1,466  from holding Agios Pharm or generate 32.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Agios Pharm  vs.  Arvinas

 Performance 
       Timeline  
Agios Pharm 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Agios Pharm are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating forward indicators, Agios Pharm displayed solid returns over the last few months and may actually be approaching a breakup point.
Arvinas 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Arvinas are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Arvinas may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Agios Pharm and Arvinas Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agios Pharm and Arvinas

The main advantage of trading using opposite Agios Pharm and Arvinas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agios Pharm position performs unexpectedly, Arvinas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will offset losses from the drop in Arvinas' long position.
The idea behind Agios Pharm and Arvinas pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance